

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | melanin biosynthetic process (GO:0042438) | 9.34193869 |
| 2 | melanin metabolic process (GO:0006582) | 8.32459082 |
| 3 | secondary metabolite biosynthetic process (GO:0044550) | 8.20628156 |
| 4 | ribosomal small subunit assembly (GO:0000028) | 7.70963117 |
| 5 | hemidesmosome assembly (GO:0031581) | 6.31559340 |
| 6 | viral transcription (GO:0019083) | 5.97661388 |
| 7 | desmosome organization (GO:0002934) | 5.76187260 |
| 8 | DNA deamination (GO:0045006) | 5.74557321 |
| 9 | translational termination (GO:0006415) | 5.71045996 |
| 10 | keratinization (GO:0031424) | 5.66292717 |
| 11 | definitive hemopoiesis (GO:0060216) | 5.43045883 |
| 12 | establishment of skin barrier (GO:0061436) | 5.41127602 |
| 13 | tyrosine metabolic process (GO:0006570) | 5.25642983 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.09439034 |
| 15 | translational elongation (GO:0006414) | 4.98850478 |
| 16 | establishment of integrated proviral latency (GO:0075713) | 4.97217212 |
| 17 | ribosomal small subunit biogenesis (GO:0042274) | 4.93882501 |
| 18 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.93246409 |
| 19 | keratinocyte proliferation (GO:0043616) | 4.88333129 |
| 20 | regulation of water loss via skin (GO:0033561) | 4.87756215 |
| 21 | response to interferon-beta (GO:0035456) | 4.85248307 |
| 22 | cotranslational protein targeting to membrane (GO:0006613) | 4.81258976 |
| 23 | protein targeting to ER (GO:0045047) | 4.77802493 |
| 24 | maturation of SSU-rRNA (GO:0030490) | 4.74434268 |
| 25 | protein localization to endoplasmic reticulum (GO:0070972) | 4.58332048 |
| 26 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.55971064 |
| 27 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.53563579 |
| 28 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.45454131 |
| 29 | viral life cycle (GO:0019058) | 4.44831584 |
| 30 | establishment of viral latency (GO:0019043) | 4.38954941 |
| 31 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.36853880 |
| 32 | lymphoid progenitor cell differentiation (GO:0002320) | 4.25333563 |
| 33 | cellular protein complex disassembly (GO:0043624) | 4.17065236 |
| 34 | translational initiation (GO:0006413) | 4.08558427 |
| 35 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.06535590 |
| 36 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.06535590 |
| 37 | megakaryocyte development (GO:0035855) | 4.05133933 |
| 38 | pigment cell differentiation (GO:0050931) | 3.88316304 |
| 39 | melanocyte differentiation (GO:0030318) | 3.85832961 |
| 40 | response to interferon-alpha (GO:0035455) | 3.75553516 |
| 41 | pigment biosynthetic process (GO:0046148) | 3.72452196 |
| 42 | positive regulation of B cell differentiation (GO:0045579) | 3.72076914 |
| 43 | protein complex disassembly (GO:0043241) | 3.71798761 |
| 44 | ribosomal large subunit biogenesis (GO:0042273) | 3.63292615 |
| 45 | keratinocyte differentiation (GO:0030216) | 3.58317108 |
| 46 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.51610556 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.49258565 |
| 48 | ribosome assembly (GO:0042255) | 3.48093682 |
| 49 | mature B cell differentiation involved in immune response (GO:0002313) | 3.47206255 |
| 50 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.46602050 |
| 51 | macromolecular complex disassembly (GO:0032984) | 3.45544440 |
| 52 | daunorubicin metabolic process (GO:0044597) | 3.42511638 |
| 53 | polyketide metabolic process (GO:0030638) | 3.42511638 |
| 54 | doxorubicin metabolic process (GO:0044598) | 3.42511638 |
| 55 | mRNA catabolic process (GO:0006402) | 3.40973583 |
| 56 | phospholipid scrambling (GO:0017121) | 3.40532780 |
| 57 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.39240180 |
| 58 | protein maturation by protein folding (GO:0022417) | 3.35745831 |
| 59 | hair cycle (GO:0042633) | 3.34186210 |
| 60 | molting cycle (GO:0042303) | 3.34186210 |
| 61 | IMP biosynthetic process (GO:0006188) | 3.27750096 |
| 62 | * platelet dense granule organization (GO:0060155) | 3.26240574 |
| 63 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.23786806 |
| 64 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.23743052 |
| 65 | necroptotic process (GO:0070266) | 3.20795507 |
| 66 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.20568719 |
| 67 | negative regulation of ligase activity (GO:0051352) | 3.19787502 |
| 68 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.19787502 |
| 69 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.19744676 |
| 70 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.19209646 |
| 71 | RNA catabolic process (GO:0006401) | 3.18966258 |
| 72 | pseudouridine synthesis (GO:0001522) | 3.18900892 |
| 73 | purine-containing compound salvage (GO:0043101) | 3.18502448 |
| 74 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.17637995 |
| 75 | respiratory chain complex IV assembly (GO:0008535) | 3.15731596 |
| 76 | protein targeting to membrane (GO:0006612) | 3.14268638 |
| 77 | defense response to protozoan (GO:0042832) | 3.12564426 |
| 78 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.11193231 |
| 79 | L-fucose catabolic process (GO:0042355) | 3.06721828 |
| 80 | fucose catabolic process (GO:0019317) | 3.06721828 |
| 81 | L-fucose metabolic process (GO:0042354) | 3.06721828 |
| 82 | cellular response to interferon-beta (GO:0035458) | 3.04294860 |
| 83 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.04282648 |
| 84 | DNA strand elongation (GO:0022616) | 3.03288067 |
| 85 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.03043916 |
| 86 | telomere maintenance via recombination (GO:0000722) | 3.02452220 |
| 87 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.01178592 |
| 88 | response to protozoan (GO:0001562) | 2.97108312 |
| 89 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.96180435 |
| 90 | epidermis development (GO:0008544) | 2.90349269 |
| 91 | protein neddylation (GO:0045116) | 2.90228485 |
| 92 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.89673790 |
| 93 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.88882800 |
| 94 | translation (GO:0006412) | 2.88872543 |
| 95 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.88029994 |
| 96 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.86568624 |
| 97 | pigment metabolic process (GO:0042440) | 2.85744402 |
| 98 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.84110169 |
| 99 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.84110169 |
| 100 | lymph node development (GO:0048535) | 2.83871136 |
| 101 | mast cell activation (GO:0045576) | 2.83416754 |
| 102 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.83379783 |
| 103 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.83379783 |
| 104 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.83379783 |
| 105 | T cell homeostasis (GO:0043029) | 2.80507014 |
| 106 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.80432442 |
| 107 | gap junction assembly (GO:0016264) | 2.78413258 |
| 108 | regulation of natural killer cell differentiation (GO:0032823) | 2.77864968 |
| 109 | chromatin remodeling at centromere (GO:0031055) | 2.77602091 |
| 110 | formation of translation preinitiation complex (GO:0001731) | 2.75682451 |
| 111 | tRNA methylation (GO:0030488) | 2.75501523 |
| 112 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.74556477 |
| 113 | multicellular organismal water homeostasis (GO:0050891) | 2.74277569 |
| 114 | mitotic nuclear envelope reassembly (GO:0007084) | 2.74075738 |
| 115 | nuclear envelope reassembly (GO:0031468) | 2.74075738 |
| 116 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.74059275 |
| 117 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.74059275 |
| 118 | positive regulation of granulocyte differentiation (GO:0030854) | 2.73163380 |
| 119 | epidermal cell differentiation (GO:0009913) | 2.71973854 |
| 120 | embryonic hemopoiesis (GO:0035162) | 2.71157022 |
| 121 | response to X-ray (GO:0010165) | 2.69918718 |
| 122 | cytokine production involved in immune response (GO:0002367) | 2.69872201 |
| 123 | DNA replication initiation (GO:0006270) | 2.68032038 |
| 124 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.67874097 |
| 125 | nucleoside salvage (GO:0043174) | 2.67647616 |
| 126 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.67343447 |
| 127 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.64916537 |
| 128 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.64465702 |
| 129 | cellular response to type I interferon (GO:0071357) | 2.64432051 |
| 130 | type I interferon signaling pathway (GO:0060337) | 2.64432051 |
| 131 | regulation of B cell differentiation (GO:0045577) | 2.64278395 |
| 132 | response to type I interferon (GO:0034340) | 2.63383449 |
| 133 | regulation of erythrocyte differentiation (GO:0045646) | 2.63029704 |
| 134 | regulation of necroptotic process (GO:0060544) | 2.62086418 |
| 135 | positive regulation of ligase activity (GO:0051351) | 2.61930011 |
| 136 | programmed necrotic cell death (GO:0097300) | 2.61410536 |
| 137 | telomere maintenance via telomere lengthening (GO:0010833) | 2.60984328 |
| 138 | cellular component biogenesis (GO:0044085) | 2.60835024 |
| 139 | keratinocyte development (GO:0003334) | 2.60792453 |
| 140 | neuroepithelial cell differentiation (GO:0060563) | 2.60339318 |
| 141 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.59959850 |
| 142 | B cell mediated immunity (GO:0019724) | 2.59358652 |
| 143 | rRNA processing (GO:0006364) | 2.59051608 |
| 144 | IMP metabolic process (GO:0046040) | 2.59037920 |
| 145 | regulation of necrotic cell death (GO:0010939) | 2.57809368 |
| 146 | mitotic recombination (GO:0006312) | 2.57381619 |
| 147 | immunoglobulin mediated immune response (GO:0016064) | 2.56885226 |
| 148 | peptidyl-proline hydroxylation (GO:0019511) | 2.56665604 |
| 149 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.55454917 |
| 150 | isotype switching (GO:0045190) | 2.55454917 |
| 151 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.55454917 |
| 152 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.54811148 |
| 153 | regulation of ligase activity (GO:0051340) | 2.54628605 |
| 154 | rRNA modification (GO:0000154) | 2.53664948 |
| 155 | proteasome assembly (GO:0043248) | 2.53457851 |
| 156 | iron-sulfur cluster assembly (GO:0016226) | 2.53376838 |
| 157 | metallo-sulfur cluster assembly (GO:0031163) | 2.53376838 |
| 158 | negative regulation of viral entry into host cell (GO:0046597) | 2.53270854 |
| 159 | purine nucleobase biosynthetic process (GO:0009113) | 2.52416462 |
| 160 | CENP-A containing nucleosome assembly (GO:0034080) | 2.50871722 |
| 161 | lipoxygenase pathway (GO:0019372) | 2.50813963 |
| 162 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.50624985 |
| 163 | cullin deneddylation (GO:0010388) | 2.50472743 |
| 164 | phenol-containing compound biosynthetic process (GO:0046189) | 2.49526272 |
| 165 | negative regulation of viral genome replication (GO:0045071) | 2.49476136 |
| 166 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.49203111 |
| 167 | muscle cell migration (GO:0014812) | 2.48880218 |
| 168 | rRNA metabolic process (GO:0016072) | 2.48750862 |
| 169 | fatty acid elongation (GO:0030497) | 2.48193866 |
| 170 | galactose catabolic process (GO:0019388) | 2.46878960 |
| 171 | regulation of keratinocyte proliferation (GO:0010837) | 2.43767194 |
| 172 | AMP metabolic process (GO:0046033) | 2.42507005 |
| 173 | pinocytosis (GO:0006907) | 2.41783616 |
| 174 | mitotic metaphase plate congression (GO:0007080) | 2.40130080 |
| 175 | protein targeting to mitochondrion (GO:0006626) | 2.39166090 |
| 176 | establishment of planar polarity (GO:0001736) | 2.38592792 |
| 177 | establishment of tissue polarity (GO:0007164) | 2.38592792 |
| 178 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.35565579 |
| 179 | L-serine metabolic process (GO:0006563) | 2.33725270 |
| 180 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.33195357 |
| 181 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.32509500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 7.08798639 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.57914247 |
| 3 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 4.38358752 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.12076594 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.61962596 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.53318018 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.25906751 |
| 8 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 3.25855260 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.24150054 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 3.09200272 |
| 11 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.01801505 |
| 12 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.94025955 |
| 13 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.87885496 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80726202 |
| 15 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.79566736 |
| 16 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76812199 |
| 17 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.76663199 |
| 18 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.63336478 |
| 19 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.59349020 |
| 20 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.42041526 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.41192737 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.39930597 |
| 23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.39310211 |
| 24 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.32885705 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.32486953 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.27077170 |
| 27 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.25993847 |
| 28 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.25243831 |
| 29 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.18435737 |
| 30 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16309417 |
| 31 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.12846772 |
| 32 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.11352431 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.10736932 |
| 34 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.06927401 |
| 35 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.06652960 |
| 36 | GATA1_22025678_ChIP-Seq_K562_Human | 2.04479892 |
| 37 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.01208653 |
| 38 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.97598175 |
| 39 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.97079368 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.93903933 |
| 41 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.93628265 |
| 42 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.92629862 |
| 43 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.91639213 |
| 44 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.88005745 |
| 45 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.85554177 |
| 46 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83845884 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.83244489 |
| 48 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.80905493 |
| 49 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80570915 |
| 50 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.80429557 |
| 51 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.79726909 |
| 52 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.77184669 |
| 53 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.76624414 |
| 54 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.75604865 |
| 55 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.75555291 |
| 56 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.74683117 |
| 57 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.73132623 |
| 58 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.67913276 |
| 59 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.66570540 |
| 60 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.66570540 |
| 61 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.62067761 |
| 62 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.61875719 |
| 63 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.61697598 |
| 64 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.59688989 |
| 65 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.56093106 |
| 66 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.52997915 |
| 67 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.50806002 |
| 68 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.50587332 |
| 69 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.50254115 |
| 70 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.48879430 |
| 71 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.48211820 |
| 72 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.47437115 |
| 73 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.46188906 |
| 74 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.44438581 |
| 75 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.44045729 |
| 76 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.43499237 |
| 77 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.42894101 |
| 78 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41965542 |
| 79 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.41479115 |
| 80 | * MYB_26560356_Chip-Seq_TH2_Human | 1.38491203 |
| 81 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.38125857 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38111601 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37696903 |
| 84 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36593162 |
| 85 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36152160 |
| 86 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.35251632 |
| 87 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.33149507 |
| 88 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.32035429 |
| 89 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.31586534 |
| 90 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31393313 |
| 91 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.28771828 |
| 92 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26394288 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 1.26206883 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25270573 |
| 95 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.24407854 |
| 96 | * MYB_26560356_Chip-Seq_TH1_Human | 1.24235131 |
| 97 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22721584 |
| 98 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.22223001 |
| 99 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.20924824 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.20840316 |
| 101 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.20721826 |
| 102 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.19762071 |
| 103 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.17259202 |
| 104 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.16887166 |
| 105 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15267040 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 1.14409748 |
| 107 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14310344 |
| 108 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.13638398 |
| 109 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.12486672 |
| 110 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.11671900 |
| 111 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.10578529 |
| 112 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09925039 |
| 113 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.09143131 |
| 114 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08502549 |
| 115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.07159096 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.05604747 |
| 117 | * ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.05522117 |
| 118 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05414529 |
| 119 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.05285520 |
| 120 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.05238427 |
| 121 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.04822773 |
| 122 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04442726 |
| 123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.02488749 |
| 124 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.01429971 |
| 125 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.00603949 |
| 126 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.98107946 |
| 127 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98032026 |
| 128 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.97952439 |
| 129 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.97527870 |
| 130 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.96939283 |
| 131 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96624637 |
| 132 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.96029114 |
| 133 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94965245 |
| 134 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94339338 |
| 135 | * NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.93543860 |
| 136 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.92885730 |
| 137 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 0.92601559 |
| 138 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.92111582 |
| 139 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.90871892 |
| 140 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.90234067 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89871479 |
| 142 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89691524 |
| 143 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.89600317 |
| 144 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.89506439 |
| 145 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.89384278 |
| 146 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.88796809 |
| 147 | * SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.88684339 |
| 148 | * NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.88337941 |
| 149 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.87706550 |
| 150 | MAF_26560356_Chip-Seq_TH2_Human | 0.87450157 |
| 151 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.86544532 |
| 152 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.84385687 |
| 153 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.83544744 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 6.39556454 |
| 2 | MP0002396_abnormal_hematopoietic_system | 4.19220150 |
| 3 | MP0000579_abnormal_nail_morphology | 3.80105053 |
| 4 | MP0005075_abnormal_melanosome_morpholog | 3.32116737 |
| 5 | MP0005174_abnormal_tail_pigmentation | 3.31068458 |
| 6 | MP0005257_abnormal_intraocular_pressure | 3.30049177 |
| 7 | MP0002796_impaired_skin_barrier | 3.10693946 |
| 8 | MP0004808_abnormal_hematopoietic_stem | 3.06383185 |
| 9 | MP0000372_irregular_coat_pigmentation | 3.01104759 |
| 10 | MP0001835_abnormal_antigen_presentation | 2.93698421 |
| 11 | MP0001545_abnormal_hematopoietic_system | 2.83291061 |
| 12 | MP0005397_hematopoietic_system_phenotyp | 2.83291061 |
| 13 | MP0000685_abnormal_immune_system | 2.67534368 |
| 14 | MP0003941_abnormal_skin_development | 2.63410773 |
| 15 | MP0010234_abnormal_vibrissa_follicle | 2.56247238 |
| 16 | MP0009785_altered_susceptibility_to | 2.56090534 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.55409683 |
| 18 | MP0004147_increased_porphyrin_level | 2.54768144 |
| 19 | MP0000465_gastrointestinal_hemorrhage | 2.40295911 |
| 20 | MP0003693_abnormal_embryo_hatching | 2.35526382 |
| 21 | * MP0002095_abnormal_skin_pigmentation | 2.24652141 |
| 22 | MP0005671_abnormal_response_to | 2.24403362 |
| 23 | MP0003763_abnormal_thymus_physiology | 2.22661654 |
| 24 | MP0000490_abnormal_crypts_of | 2.19293303 |
| 25 | MP0009379_abnormal_foot_pigmentation | 2.17089162 |
| 26 | MP0001986_abnormal_taste_sensitivity | 2.15827692 |
| 27 | MP0008007_abnormal_cellular_replicative | 2.06587630 |
| 28 | MP0002398_abnormal_bone_marrow | 2.00614263 |
| 29 | MP0005501_abnormal_skin_physiology | 1.96953986 |
| 30 | MP0005025_abnormal_response_to | 1.96853381 |
| 31 | MP0003453_abnormal_keratinocyte_physiol | 1.95328835 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.93118332 |
| 33 | MP0005275_abnormal_skin_tensile | 1.86334393 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.82710275 |
| 35 | MP0003806_abnormal_nucleotide_metabolis | 1.81956997 |
| 36 | MP0002166_altered_tumor_susceptibility | 1.81579788 |
| 37 | MP0000015_abnormal_ear_pigmentation | 1.80836965 |
| 38 | MP0008058_abnormal_DNA_repair | 1.78769841 |
| 39 | MP0001216_abnormal_epidermal_layer | 1.75783055 |
| 40 | MP0010678_abnormal_skin_adnexa | 1.75608712 |
| 41 | MP0001800_abnormal_humoral_immune | 1.74481647 |
| 42 | MP0000689_abnormal_spleen_morphology | 1.74420091 |
| 43 | MP0002060_abnormal_skin_morphology | 1.71256190 |
| 44 | MP0002148_abnormal_hypersensitivity_rea | 1.71064321 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.70198131 |
| 46 | MP0001853_heart_inflammation | 1.69563889 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.68290441 |
| 48 | MP0001873_stomach_inflammation | 1.68106356 |
| 49 | MP0006054_spinal_hemorrhage | 1.67429415 |
| 50 | MP0002723_abnormal_immune_serum | 1.67179413 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.66330341 |
| 52 | MP0000762_abnormal_tongue_morphology | 1.65472966 |
| 53 | MP0001819_abnormal_immune_cell | 1.65296456 |
| 54 | MP0002722_abnormal_immune_system | 1.63720838 |
| 55 | MP0005248_abnormal_Harderian_gland | 1.63677373 |
| 56 | MP0003724_increased_susceptibility_to | 1.63124140 |
| 57 | MP0003436_decreased_susceptibility_to | 1.63110273 |
| 58 | MP0000716_abnormal_immune_system | 1.57541586 |
| 59 | MP0010155_abnormal_intestine_physiology | 1.56978626 |
| 60 | MP0003077_abnormal_cell_cycle | 1.56396418 |
| 61 | MP0004272_abnormal_basement_membrane | 1.55178700 |
| 62 | MP0006292_abnormal_olfactory_placode | 1.54910779 |
| 63 | MP0002429_abnormal_blood_cell | 1.53911692 |
| 64 | MP0002006_tumorigenesis | 1.53460163 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.53357801 |
| 66 | MP0004957_abnormal_blastocyst_morpholog | 1.50623397 |
| 67 | MP0005000_abnormal_immune_tolerance | 1.49436576 |
| 68 | MP0003943_abnormal_hepatobiliary_system | 1.44481396 |
| 69 | MP0003866_abnormal_defecation | 1.41697250 |
| 70 | MP0002419_abnormal_innate_immunity | 1.39589287 |
| 71 | MP0000383_abnormal_hair_follicle | 1.38229802 |
| 72 | MP0000377_abnormal_hair_follicle | 1.35681385 |
| 73 | MP0000647_abnormal_sebaceous_gland | 1.35628745 |
| 74 | MP0001849_ear_inflammation | 1.34952324 |
| 75 | MP0002132_abnormal_respiratory_system | 1.34914754 |
| 76 | MP0001348_abnormal_lacrimal_gland | 1.30657934 |
| 77 | MP0000467_abnormal_esophagus_morphology | 1.29399444 |
| 78 | MP0010771_integument_phenotype | 1.29083507 |
| 79 | MP0008932_abnormal_embryonic_tissue | 1.28248142 |
| 80 | * MP0001324_abnormal_eye_pigmentation | 1.28195875 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 1.27202811 |
| 82 | MP0000569_abnormal_digit_pigmentation | 1.25629152 |
| 83 | MP0009053_abnormal_anal_canal | 1.25297428 |
| 84 | * MP0005197_abnormal_uvea_morphology | 1.24537172 |
| 85 | MP0005387_immune_system_phenotype | 1.23789822 |
| 86 | MP0001790_abnormal_immune_system | 1.23789822 |
| 87 | MP0000371_diluted_coat_color | 1.22686550 |
| 88 | MP0000703_abnormal_thymus_morphology | 1.22634311 |
| 89 | MP0005377_hearing/vestibular/ear_phenot | 1.21233516 |
| 90 | MP0003878_abnormal_ear_physiology | 1.21233516 |
| 91 | MP0003786_premature_aging | 1.20462598 |
| 92 | MP0005058_abnormal_lysosome_morphology | 1.19797165 |
| 93 | MP0004381_abnormal_hair_follicle | 1.19416657 |
| 94 | MP0001188_hyperpigmentation | 1.19109507 |
| 95 | MP0002019_abnormal_tumor_incidence | 1.18815434 |
| 96 | MP0002098_abnormal_vibrissa_morphology | 1.18539376 |
| 97 | MP0002405_respiratory_system_inflammati | 1.16754478 |
| 98 | MP0003111_abnormal_nucleus_morphology | 1.15719660 |
| 99 | MP0003950_abnormal_plasma_membrane | 1.14838342 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 1.13385395 |
| 101 | MP0008260_abnormal_autophagy | 1.12063944 |
| 102 | MP0010368_abnormal_lymphatic_system | 1.11561761 |
| 103 | MP0005409_darkened_coat_color | 1.11259660 |
| 104 | MP0002177_abnormal_outer_ear | 1.09967046 |
| 105 | MP0002938_white_spotting | 1.09752656 |
| 106 | MP0009697_abnormal_copulation | 1.09440824 |
| 107 | MP0009278_abnormal_bone_marrow | 1.04382266 |
| 108 | MP0001845_abnormal_inflammatory_respons | 1.03730730 |
| 109 | MP0002009_preneoplasia | 1.02190935 |
| 110 | MP0008057_abnormal_DNA_replication | 0.97731457 |
| 111 | MP0000313_abnormal_cell_death | 0.97419542 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.96807404 |
| 113 | MP0003718_maternal_effect | 0.95954376 |
| 114 | MP0002090_abnormal_vision | 0.95429569 |
| 115 | MP0008469_abnormal_protein_level | 0.95018212 |
| 116 | MP0003186_abnormal_redox_activity | 0.94213119 |
| 117 | MP0006036_abnormal_mitochondrial_physio | 0.94041774 |
| 118 | * MP0002075_abnormal_coat/hair_pigmentati | 0.93720651 |
| 119 | MP0005023_abnormal_wound_healing | 0.92084625 |
| 120 | MP0004947_skin_inflammation | 0.90189204 |
| 121 | * MP0000367_abnormal_coat/_hair | 0.89192092 |
| 122 | MP0000358_abnormal_cell_content/ | 0.86294526 |
| 123 | MP0008789_abnormal_olfactory_epithelium | 0.85799438 |
| 124 | MP0005408_hypopigmentation | 0.85036392 |
| 125 | MP0003567_abnormal_fetal_cardiomyocyte | 0.84478072 |
| 126 | MP0003136_yellow_coat_color | 0.82900043 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.81918119 |
| 128 | MP0002234_abnormal_pharynx_morphology | 0.80908800 |
| 129 | MP0001293_anophthalmia | 0.80404657 |
| 130 | MP0003011_delayed_dark_adaptation | 0.76587601 |
| 131 | MP0005310_abnormal_salivary_gland | 0.75763218 |
| 132 | MP0003191_abnormal_cellular_cholesterol | 0.75647520 |
| 133 | MP0000566_synostosis | 0.73581190 |
| 134 | MP0003705_abnormal_hypodermis_morpholog | 0.72027979 |
| 135 | MP0008995_early_reproductive_senescence | 0.71999348 |
| 136 | MP0002282_abnormal_trachea_morphology | 0.71803604 |
| 137 | MP0002697_abnormal_eye_size | 0.71761650 |
| 138 | * MP0005193_abnormal_anterior_eye | 0.69106470 |
| 139 | MP0004264_abnormal_extraembryonic_tissu | 0.65613036 |
| 140 | MP0000477_abnormal_intestine_morphology | 0.64098097 |
| 141 | MP0001119_abnormal_female_reproductive | 0.62929279 |
| 142 | MP0005394_taste/olfaction_phenotype | 0.62710279 |
| 143 | MP0005499_abnormal_olfactory_system | 0.62710279 |
| 144 | MP0009931_abnormal_skin_appearance | 0.62380017 |
| 145 | MP0001851_eye_inflammation | 0.62052553 |
| 146 | MP0009763_increased_sensitivity_to | 0.61553325 |
| 147 | MP0003638_abnormal_response/metabolism_ | 0.60392161 |
| 148 | MP0003315_abnormal_perineum_morphology | 0.59844550 |
| 149 | MP0001764_abnormal_homeostasis | 0.59156440 |
| 150 | MP0002233_abnormal_nose_morphology | 0.58818347 |
| 151 | MP0002102_abnormal_ear_morphology | 0.58164821 |
| 152 | MP0001299_abnormal_eye_distance/ | 0.56459033 |
| 153 | MP0000678_abnormal_parathyroid_gland | 0.56323755 |
| 154 | * MP0001186_pigmentation_phenotype | 0.56116970 |
| 155 | MP0000350_abnormal_cell_proliferation | 0.55407579 |
| 156 | MP0003172_abnormal_lysosome_physiology | 0.53278458 |
| 157 | MP0001191_abnormal_skin_condition | 0.53240640 |
| 158 | MP0004782_abnormal_surfactant_physiolog | 0.53199351 |
| 159 | MP0010352_gastrointestinal_tract_polyps | 0.50426993 |
| 160 | MP0000858_altered_metastatic_potential | 0.49876226 |
| 161 | MP0002111_abnormal_tail_morphology | 0.49522152 |
| 162 | MP0001340_abnormal_eyelid_morphology | 0.48146604 |
| 163 | MP0000427_abnormal_hair_cycle | 0.46448054 |
| 164 | MP0002254_reproductive_system_inflammat | 0.45572147 |
| 165 | MP0000627_abnormal_mammary_gland | 0.44781270 |
| 166 | MP0003755_abnormal_palate_morphology | 0.43504188 |
| 167 | MP0002089_abnormal_postnatal_growth/wei | 0.42236332 |
| 168 | MP0008438_abnormal_cutaneous_collagen | 0.41728991 |
| 169 | MP0001243_abnormal_dermal_layer | 0.41602096 |
| 170 | MP0004885_abnormal_endolymph | 0.41238286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of nail color (HP:0100643) | 6.36028428 |
| 2 | Onycholysis (HP:0001806) | 6.16447977 |
| 3 | Thrombocytosis (HP:0001894) | 5.93309505 |
| 4 | Aplastic anemia (HP:0001915) | 5.77040652 |
| 5 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.59661463 |
| 6 | Abnormal number of erythroid precursors (HP:0012131) | 5.51710322 |
| 7 | Plantar hyperkeratosis (HP:0007556) | 5.47622984 |
| 8 | Hypoplasia of the fovea (HP:0007750) | 5.32490124 |
| 9 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 5.32490124 |
| 10 | Palmoplantar hyperkeratosis (HP:0000972) | 5.21997342 |
| 11 | Palmar hyperkeratosis (HP:0010765) | 5.09006798 |
| 12 | Thick nail (HP:0001805) | 4.96623850 |
| 13 | Abnormality of the fovea (HP:0000493) | 4.69064463 |
| 14 | Reticulocytopenia (HP:0001896) | 4.40269292 |
| 15 | Alopecia of scalp (HP:0002293) | 4.27441119 |
| 16 | Petechiae (HP:0000967) | 4.24176403 |
| 17 | Prolonged bleeding time (HP:0003010) | 4.13716386 |
| 18 | Fragile nails (HP:0001808) | 4.10115522 |
| 19 | Myositis (HP:0100614) | 4.09863597 |
| 20 | Chronic otitis media (HP:0000389) | 4.06012497 |
| 21 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.04025671 |
| 22 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.00610216 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.87035788 |
| 24 | Blue irides (HP:0000635) | 3.85735774 |
| 25 | Milia (HP:0001056) | 3.74290897 |
| 26 | IgM deficiency (HP:0002850) | 3.73761324 |
| 27 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 3.69916547 |
| 28 | Sparse eyelashes (HP:0000653) | 3.64138758 |
| 29 | Reduced antithrombin III activity (HP:0001976) | 3.53198950 |
| 30 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.51083276 |
| 31 | Type I transferrin isoform profile (HP:0003642) | 3.47042691 |
| 32 | Nail dystrophy (HP:0008404) | 3.42588990 |
| 33 | Erythroderma (HP:0001019) | 3.36838550 |
| 34 | Iris hypopigmentation (HP:0007730) | 3.35978943 |
| 35 | Muscle fiber atrophy (HP:0100295) | 3.35100290 |
| 36 | Pallor (HP:0000980) | 3.33462891 |
| 37 | Type 2 muscle fiber atrophy (HP:0003554) | 3.32776726 |
| 38 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.23201710 |
| 39 | Hypopigmentation of the fundus (HP:0007894) | 3.21295472 |
| 40 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20133345 |
| 41 | Pili torti (HP:0003777) | 3.17539935 |
| 42 | Epistaxis (HP:0000421) | 3.14777785 |
| 43 | Heterochromia iridis (HP:0001100) | 3.10586806 |
| 44 | Albinism (HP:0001022) | 3.09272675 |
| 45 | Abnormality of T cell physiology (HP:0011840) | 2.99838597 |
| 46 | Acute myeloid leukemia (HP:0004808) | 2.99414891 |
| 47 | Macrocytic anemia (HP:0001972) | 2.96922284 |
| 48 | Erythema (HP:0010783) | 2.94756422 |
| 49 | Impaired platelet aggregation (HP:0003540) | 2.90714656 |
| 50 | Abnormal platelet function (HP:0011869) | 2.90714656 |
| 51 | Myelodysplasia (HP:0002863) | 2.88776571 |
| 52 | Amaurosis fugax (HP:0100576) | 2.88399856 |
| 53 | Abnormality of the nasal mucosa (HP:0000433) | 2.83978008 |
| 54 | Ridged nail (HP:0001807) | 2.82672320 |
| 55 | Abnormal auditory evoked potentials (HP:0006958) | 2.81540734 |
| 56 | Abnormal protein glycosylation (HP:0012346) | 2.81110457 |
| 57 | Abnormal glycosylation (HP:0012345) | 2.81110457 |
| 58 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.81110457 |
| 59 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.81110457 |
| 60 | Pancytopenia (HP:0001876) | 2.80345357 |
| 61 | Abnormal hair laboratory examination (HP:0003328) | 2.74062019 |
| 62 | Natal tooth (HP:0000695) | 2.72767802 |
| 63 | Absent eyelashes (HP:0000561) | 2.64933285 |
| 64 | Abnormal blistering of the skin (HP:0008066) | 2.64815609 |
| 65 | Atrophic scars (HP:0001075) | 2.63795592 |
| 66 | Abnormality of the prostate (HP:0008775) | 2.62151132 |
| 67 | Amniotic constriction ring (HP:0009775) | 2.61364689 |
| 68 | Abnormality of placental membranes (HP:0011409) | 2.61364689 |
| 69 | Right ventricular cardiomyopathy (HP:0011663) | 2.54173568 |
| 70 | Freckling (HP:0001480) | 2.53260088 |
| 71 | Cholecystitis (HP:0001082) | 2.53157822 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.53157822 |
| 73 | Nasal polyposis (HP:0100582) | 2.52644231 |
| 74 | Panhypogammaglobulinemia (HP:0003139) | 2.50931328 |
| 75 | Poikiloderma (HP:0001029) | 2.50435393 |
| 76 | Selective tooth agenesis (HP:0001592) | 2.49754371 |
| 77 | Hypotrichosis (HP:0001006) | 2.48704938 |
| 78 | Purpura (HP:0000979) | 2.45600409 |
| 79 | Lip pit (HP:0100267) | 2.43924780 |
| 80 | Colon cancer (HP:0003003) | 2.43343046 |
| 81 | Patchy hypopigmentation of hair (HP:0011365) | 2.42582564 |
| 82 | Abnormality of glycolysis (HP:0004366) | 2.42581668 |
| 83 | Abnormality of the salivary glands (HP:0010286) | 2.40376883 |
| 84 | Gingival bleeding (HP:0000225) | 2.39386551 |
| 85 | Sparse scalp hair (HP:0002209) | 2.37034875 |
| 86 | Acute lymphatic leukemia (HP:0006721) | 2.35868673 |
| 87 | Increased serum pyruvate (HP:0003542) | 2.35787322 |
| 88 | Abnormality of the axillary hair (HP:0100134) | 2.35252006 |
| 89 | Abnormality of secondary sexual hair (HP:0009888) | 2.35252006 |
| 90 | Oral leukoplakia (HP:0002745) | 2.34894289 |
| 91 | Microcytic anemia (HP:0001935) | 2.33180829 |
| 92 | Recurrent bronchitis (HP:0002837) | 2.31001966 |
| 93 | Osteolytic defects of the hand bones (HP:0009699) | 2.28676574 |
| 94 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.28676574 |
| 95 | Orchitis (HP:0100796) | 2.25428021 |
| 96 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.25340441 |
| 97 | Nonprogressive disorder (HP:0003680) | 2.25090749 |
| 98 | Woolly hair (HP:0002224) | 2.24532428 |
| 99 | Dry hair (HP:0011359) | 2.24293389 |
| 100 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.24224765 |
| 101 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.24224765 |
| 102 | Birth length less than 3rd percentile (HP:0003561) | 2.23196951 |
| 103 | Hypothermia (HP:0002045) | 2.22285252 |
| 104 | Microretrognathia (HP:0000308) | 2.18855628 |
| 105 | Severe visual impairment (HP:0001141) | 2.17755732 |
| 106 | Agammaglobulinemia (HP:0004432) | 2.17532765 |
| 107 | White forelock (HP:0002211) | 2.14850648 |
| 108 | Corneal erosion (HP:0200020) | 2.14651375 |
| 109 | Recurrent bacterial skin infections (HP:0005406) | 2.12900190 |
| 110 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.12826346 |
| 111 | Absent hair (HP:0002298) | 2.11283946 |
| 112 | IgG deficiency (HP:0004315) | 2.11115063 |
| 113 | Interstitial pulmonary disease (HP:0006530) | 2.08403401 |
| 114 | Encephalitis (HP:0002383) | 2.07774580 |
| 115 | Recurrent abscess formation (HP:0002722) | 2.07491897 |
| 116 | Ocular albinism (HP:0001107) | 2.07058185 |
| 117 | Recurrent viral infections (HP:0004429) | 2.06973519 |
| 118 | Retrobulbar optic neuritis (HP:0100654) | 2.05485101 |
| 119 | Optic neuritis (HP:0100653) | 2.05485101 |
| 120 | Pterygium (HP:0001059) | 2.04196866 |
| 121 | 11 pairs of ribs (HP:0000878) | 2.04126967 |
| 122 | Parakeratosis (HP:0001036) | 2.03870934 |
| 123 | Palmoplantar keratoderma (HP:0000982) | 2.02251300 |
| 124 | Ectropion (HP:0000656) | 2.01379185 |
| 125 | Lymphoma (HP:0002665) | 2.01033038 |
| 126 | Spastic paraparesis (HP:0002313) | 1.98657497 |
| 127 | Abnormality of T cells (HP:0002843) | 1.95893163 |
| 128 | Hypoplasia of the iris (HP:0007676) | 1.95842161 |
| 129 | Cellulitis (HP:0100658) | 1.94717718 |
| 130 | Spontaneous hematomas (HP:0007420) | 1.92977294 |
| 131 | Hypoproteinemia (HP:0003075) | 1.92800808 |
| 132 | Hypohidrosis (HP:0000966) | 1.92741773 |
| 133 | Neutropenia (HP:0001875) | 1.92542919 |
| 134 | Abnormality of the columella (HP:0009929) | 1.92505872 |
| 135 | Gastrointestinal inflammation (HP:0004386) | 1.90908983 |
| 136 | Hepatocellular necrosis (HP:0001404) | 1.89200401 |
| 137 | Paralysis (HP:0003470) | 1.88768027 |
| 138 | Gastrointestinal stroma tumor (HP:0100723) | 1.88615740 |
| 139 | Abnormality of glycolipid metabolism (HP:0010969) | 1.88269244 |
| 140 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.88269244 |
| 141 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.88269244 |
| 142 | Increased IgE level (HP:0003212) | 1.86077373 |
| 143 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.86065020 |
| 144 | Meningitis (HP:0001287) | 1.85711511 |
| 145 | Migraine (HP:0002076) | 1.85225399 |
| 146 | Congenital sensorineural hearing impairment (HP:0008527) | 1.84663720 |
| 147 | Entropion (HP:0000621) | 1.83674378 |
| 148 | Asplenia (HP:0001746) | 1.83566905 |
| 149 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.83526399 |
| 150 | Gonadotropin excess (HP:0000837) | 1.83475798 |
| 151 | Arterial thrombosis (HP:0004420) | 1.82660051 |
| 152 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82327028 |
| 153 | Abnormality of DNA repair (HP:0003254) | 1.80745213 |
| 154 | Rough bone trabeculation (HP:0100670) | 1.78072798 |
| 155 | Premature graying of hair (HP:0002216) | 1.74755930 |
| 156 | Lymphopenia (HP:0001888) | 1.74420794 |
| 157 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 1.74411456 |
| 158 | Hepatic necrosis (HP:0002605) | 1.72031157 |
| 159 | Bone marrow hypocellularity (HP:0005528) | 1.71646280 |
| 160 | 3-Methylglutaconic aciduria (HP:0003535) | 1.71356035 |
| 161 | Inflammation of the large intestine (HP:0002037) | 1.71149023 |
| 162 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.70880297 |
| 163 | Weak cry (HP:0001612) | 1.70638338 |
| 164 | Fatigue (HP:0012378) | 1.68747626 |
| 165 | Abnormality of methionine metabolism (HP:0010901) | 1.68536866 |
| 166 | Cutaneous melanoma (HP:0012056) | 1.68397574 |
| 167 | Short nail (HP:0001799) | 1.68195663 |
| 168 | Stenosis of the external auditory canal (HP:0000402) | 1.67605338 |
| 169 | Generalized hypopigmentation (HP:0007513) | 1.67009156 |
| 170 | Pulmonary fibrosis (HP:0002206) | 1.66119493 |
| 171 | Duplicated collecting system (HP:0000081) | 1.64917309 |
| 172 | Popliteal pterygium (HP:0009756) | 1.64530426 |
| 173 | Aplasia cutis congenita (HP:0001057) | 1.64384798 |
| 174 | Facial cleft (HP:0002006) | 1.64267175 |
| 175 | Breast aplasia (HP:0100783) | 1.63156827 |
| 176 | Hypoplastic labia majora (HP:0000059) | 1.63071434 |
| 177 | Pustule (HP:0200039) | 1.63061973 |
| 178 | Premature loss of primary teeth (HP:0006323) | 1.62449889 |
| 179 | Blepharitis (HP:0000498) | 1.62069117 |
| 180 | Breast hypoplasia (HP:0003187) | 1.57368753 |
| 181 | Vertebral compression fractures (HP:0002953) | 1.57049101 |
| 182 | Axonal loss (HP:0003447) | 1.55900785 |
| 183 | Hypoplastic pelvis (HP:0008839) | 1.54374568 |
| 184 | Median cleft lip (HP:0000161) | 1.53026116 |
| 185 | Exercise-induced muscle cramps (HP:0003710) | 1.52956914 |
| 186 | Generalized hypopigmentation of hair (HP:0011358) | 1.52069561 |
| 187 | Anonychia (HP:0001798) | 1.52024611 |
| 188 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.51675055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 3.70380052 |
| 2 | KIT | 3.56688919 |
| 3 | FLT3 | 3.15946749 |
| 4 | TGFBR1 | 3.11618479 |
| 5 | MUSK | 3.11519274 |
| 6 | MST4 | 2.87538816 |
| 7 | PBK | 2.80056258 |
| 8 | STK16 | 2.79503780 |
| 9 | TNIK | 2.75611251 |
| 10 | ACVR1B | 2.74868552 |
| 11 | NME2 | 2.66527649 |
| 12 | EEF2K | 2.65398279 |
| 13 | WEE1 | 2.59565007 |
| 14 | MET | 2.45573822 |
| 15 | CDK19 | 2.40397143 |
| 16 | EPHA2 | 2.33920401 |
| 17 | TEC | 2.31811486 |
| 18 | MAP4K1 | 2.13028585 |
| 19 | TESK1 | 2.12350426 |
| 20 | BTK | 2.12303999 |
| 21 | MAP3K12 | 2.09901335 |
| 22 | NEK1 | 2.08794488 |
| 23 | RPS6KB2 | 2.08073921 |
| 24 | STK24 | 2.06001980 |
| 25 | MAP3K3 | 2.04512201 |
| 26 | MAPKAPK3 | 2.03441545 |
| 27 | MATK | 1.93394019 |
| 28 | TRIM28 | 1.89856079 |
| 29 | EPHB2 | 1.82086937 |
| 30 | TIE1 | 1.80336081 |
| 31 | TESK2 | 1.74773979 |
| 32 | MAPKAPK5 | 1.73988772 |
| 33 | TGFBR2 | 1.73973369 |
| 34 | MAP2K3 | 1.68479443 |
| 35 | CSF1R | 1.66685280 |
| 36 | LIMK1 | 1.65542079 |
| 37 | LMTK2 | 1.63928636 |
| 38 | PIM2 | 1.57827514 |
| 39 | VRK1 | 1.57186316 |
| 40 | JAK3 | 1.54239345 |
| 41 | MKNK1 | 1.51870786 |
| 42 | CDK8 | 1.51293707 |
| 43 | ARAF | 1.46987866 |
| 44 | TXK | 1.42251098 |
| 45 | TBK1 | 1.37195949 |
| 46 | BRSK2 | 1.33128620 |
| 47 | DYRK3 | 1.32800111 |
| 48 | PLK3 | 1.31134864 |
| 49 | IKBKE | 1.30480620 |
| 50 | ERBB3 | 1.30240794 |
| 51 | TTK | 1.29377776 |
| 52 | MAP3K6 | 1.29291540 |
| 53 | TSSK6 | 1.26217403 |
| 54 | ZAP70 | 1.25823638 |
| 55 | MAP2K6 | 1.21585558 |
| 56 | ABL2 | 1.17215608 |
| 57 | TAF1 | 1.15928070 |
| 58 | STK3 | 1.13007020 |
| 59 | SYK | 1.11087483 |
| 60 | BUB1 | 1.10941190 |
| 61 | ZAK | 1.10260526 |
| 62 | BMPR1B | 1.08914039 |
| 63 | NLK | 1.07511332 |
| 64 | IKBKB | 1.06456560 |
| 65 | BMX | 1.05907438 |
| 66 | FER | 1.05094419 |
| 67 | ADRBK2 | 1.03081144 |
| 68 | CAMKK2 | 1.02463894 |
| 69 | PTK2 | 1.02388350 |
| 70 | PASK | 1.01387197 |
| 71 | BCKDK | 1.00115869 |
| 72 | CSNK1G3 | 1.00095790 |
| 73 | BCR | 0.99634654 |
| 74 | CCNB1 | 0.99086008 |
| 75 | CDK7 | 0.96747514 |
| 76 | TAOK3 | 0.96670768 |
| 77 | LRRK2 | 0.91115202 |
| 78 | NUAK1 | 0.88403457 |
| 79 | MARK3 | 0.87053813 |
| 80 | PIK3CG | 0.86555012 |
| 81 | CSNK1G1 | 0.85493421 |
| 82 | CSNK1A1L | 0.85269801 |
| 83 | FGFR1 | 0.82977908 |
| 84 | LYN | 0.82429398 |
| 85 | MKNK2 | 0.80668835 |
| 86 | ERBB4 | 0.79271867 |
| 87 | CSNK1G2 | 0.79124143 |
| 88 | KDR | 0.79101002 |
| 89 | STK38L | 0.77072569 |
| 90 | TYK2 | 0.76703471 |
| 91 | SCYL2 | 0.76169365 |
| 92 | PIM1 | 0.75905458 |
| 93 | LCK | 0.74124886 |
| 94 | PRKG2 | 0.72811875 |
| 95 | PAK4 | 0.72718714 |
| 96 | PDK2 | 0.72471159 |
| 97 | CDK9 | 0.71918201 |
| 98 | RPS6KA4 | 0.71515245 |
| 99 | IRAK4 | 0.69061438 |
| 100 | TRPM7 | 0.68463658 |
| 101 | MST1R | 0.67155749 |
| 102 | NME1 | 0.67089665 |
| 103 | ATR | 0.67071969 |
| 104 | NEK2 | 0.67071705 |
| 105 | MYLK | 0.66541317 |
| 106 | EIF2AK3 | 0.63127269 |
| 107 | EIF2AK1 | 0.63101709 |
| 108 | SRPK1 | 0.61889847 |
| 109 | GSK3A | 0.61026751 |
| 110 | TNK2 | 0.60966748 |
| 111 | RAF1 | 0.58568715 |
| 112 | AURKA | 0.58119012 |
| 113 | CAMK1 | 0.55447590 |
| 114 | FGR | 0.54952166 |
| 115 | CHUK | 0.54507827 |
| 116 | GRK7 | 0.54312620 |
| 117 | AKT2 | 0.53965994 |
| 118 | FES | 0.53461223 |
| 119 | CDC7 | 0.52446781 |
| 120 | DAPK1 | 0.52296632 |
| 121 | PKN2 | 0.50735602 |
| 122 | CDK4 | 0.50670516 |
| 123 | DDR2 | 0.50499282 |
| 124 | AURKB | 0.49413236 |
| 125 | LATS2 | 0.48769259 |
| 126 | MAP3K14 | 0.48144783 |
| 127 | RIPK1 | 0.48031044 |
| 128 | CDK6 | 0.47906891 |
| 129 | ILK | 0.47502358 |
| 130 | EIF2AK2 | 0.47177521 |
| 131 | MAP3K13 | 0.46592256 |
| 132 | PAK1 | 0.46541545 |
| 133 | PLK2 | 0.45750648 |
| 134 | STK10 | 0.44658710 |
| 135 | BRAF | 0.44586688 |
| 136 | MOS | 0.44035174 |
| 137 | MAPK11 | 0.42287799 |
| 138 | HIPK2 | 0.39980721 |
| 139 | DAPK3 | 0.39528293 |
| 140 | LATS1 | 0.39116995 |
| 141 | SIK3 | 0.39019602 |
| 142 | MAPK4 | 0.38219883 |
| 143 | PLK4 | 0.38182051 |
| 144 | RPS6KA5 | 0.37105877 |
| 145 | MAP3K8 | 0.36377693 |
| 146 | MAP3K11 | 0.36303666 |
| 147 | PLK1 | 0.36204498 |
| 148 | IRAK3 | 0.35546457 |
| 149 | BLK | 0.35300846 |
| 150 | BRSK1 | 0.35263098 |
| 151 | TAOK2 | 0.34882195 |
| 152 | PIK3CA | 0.34229507 |
| 153 | PINK1 | 0.33991528 |
| 154 | CLK1 | 0.33984297 |
| 155 | CDK3 | 0.33702117 |
| 156 | CHEK2 | 0.31185891 |
| 157 | CSNK2A1 | 0.30521521 |
| 158 | NEK9 | 0.30401020 |
| 159 | MAP4K2 | 0.29610098 |
| 160 | CDK18 | 0.29392787 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.39305689 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.33692649 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.36820976 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.79319503 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.70586038 |
| 6 | Base excision repair_Homo sapiens_hsa03410 | 2.68863147 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.54184336 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.50933912 |
| 9 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.44518382 |
| 10 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.33404694 |
| 11 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.23825615 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.10058447 |
| 13 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.07833431 |
| 14 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.92537206 |
| 15 | RNA degradation_Homo sapiens_hsa03018 | 1.91699964 |
| 16 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.90929311 |
| 17 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.90838521 |
| 18 | Proteasome_Homo sapiens_hsa03050 | 1.83228572 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81954615 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.80197732 |
| 21 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.71858939 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69162083 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64232214 |
| 24 | Cell cycle_Homo sapiens_hsa04110 | 1.60934144 |
| 25 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.60905113 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.50675376 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.50024785 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.49246412 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.47936761 |
| 30 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.47548057 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.46485122 |
| 32 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.37158872 |
| 33 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.35651268 |
| 34 | Purine metabolism_Homo sapiens_hsa00230 | 1.34451285 |
| 35 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.29301654 |
| 36 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.28970696 |
| 37 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.27821071 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.27798471 |
| 39 | RNA transport_Homo sapiens_hsa03013 | 1.27753020 |
| 40 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.27689388 |
| 41 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.27191818 |
| 42 | Measles_Homo sapiens_hsa05162 | 1.25780506 |
| 43 | Huntingtons disease_Homo sapiens_hsa05016 | 1.22873594 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.22541737 |
| 45 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.19864919 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.19714269 |
| 47 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.15714275 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14101405 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 1.13902624 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.13286052 |
| 51 | Protein export_Homo sapiens_hsa03060 | 1.13191545 |
| 52 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.10904181 |
| 53 | Leishmaniasis_Homo sapiens_hsa05140 | 1.08494052 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.07364954 |
| 55 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.06764171 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06334477 |
| 57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.05623859 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.03898039 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.03508689 |
| 60 | Adherens junction_Homo sapiens_hsa04520 | 1.02166366 |
| 61 | Alzheimers disease_Homo sapiens_hsa05010 | 0.99094239 |
| 62 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97118337 |
| 63 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.94385079 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.93719418 |
| 65 | Shigellosis_Homo sapiens_hsa05131 | 0.93187198 |
| 66 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92562619 |
| 67 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.91382797 |
| 68 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91228007 |
| 69 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.90678072 |
| 70 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.88241875 |
| 71 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87049933 |
| 72 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.86904936 |
| 73 | Allograft rejection_Homo sapiens_hsa05330 | 0.86862546 |
| 74 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.86465595 |
| 75 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.84830894 |
| 76 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.80894297 |
| 77 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.80429235 |
| 78 | Legionellosis_Homo sapiens_hsa05134 | 0.79765147 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79529408 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77634076 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76758785 |
| 82 | Influenza A_Homo sapiens_hsa05164 | 0.75761783 |
| 83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.75567360 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.73114255 |
| 85 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.72296091 |
| 86 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.72161402 |
| 87 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.71087168 |
| 88 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.70958467 |
| 89 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70769587 |
| 90 | Asthma_Homo sapiens_hsa05310 | 0.70733009 |
| 91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70666767 |
| 92 | Hepatitis B_Homo sapiens_hsa05161 | 0.69775382 |
| 93 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.69678346 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.67145669 |
| 95 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.65999314 |
| 96 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.65743141 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64115035 |
| 98 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.61435697 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57434127 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.57369351 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57110755 |
| 102 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54231651 |
| 103 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.52102337 |
| 104 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.51744406 |
| 105 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50742260 |
| 106 | Peroxisome_Homo sapiens_hsa04146 | 0.50727899 |
| 107 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.50346007 |
| 108 | Apoptosis_Homo sapiens_hsa04210 | 0.49707292 |
| 109 | Pertussis_Homo sapiens_hsa05133 | 0.49584975 |
| 110 | Malaria_Homo sapiens_hsa05144 | 0.49584146 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.47845859 |
| 112 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47342473 |
| 113 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.45920910 |
| 114 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.43802384 |
| 115 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.43734557 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43605425 |
| 117 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42097017 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.41112234 |
| 119 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.40593649 |
| 120 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40186565 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38776232 |
| 122 | Hepatitis C_Homo sapiens_hsa05160 | 0.38200089 |
| 123 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.37769222 |
| 124 | Bladder cancer_Homo sapiens_hsa05219 | 0.37193941 |
| 125 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36598987 |
| 126 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35964713 |
| 127 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.35636703 |
| 128 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.35290165 |
| 129 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.33031843 |
| 130 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.32677207 |
| 131 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.31760364 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.31131198 |
| 133 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.30378793 |
| 134 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.28813654 |
| 135 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.26960709 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.26715561 |
| 137 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.23968618 |
| 138 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.23685968 |
| 139 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22943287 |
| 140 | ABC transporters_Homo sapiens_hsa02010 | 0.22776030 |
| 141 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22494192 |
| 142 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.22313483 |
| 143 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.20648342 |
| 144 | Melanoma_Homo sapiens_hsa05218 | 0.20330408 |
| 145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19878666 |
| 146 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.19749710 |
| 147 | Melanogenesis_Homo sapiens_hsa04916 | 0.19581620 |
| 148 | Salmonella infection_Homo sapiens_hsa05132 | 0.19183703 |
| 149 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.18821500 |
| 150 | Amoebiasis_Homo sapiens_hsa05146 | 0.17919352 |

